Uses of Antibody Panels in the Analysis of Metastatic Carcinomas of Unknown Primary (Symposium VIIIDiagnostic Histochemistry : Recent Advances and Applications)
スポンサーリンク
概要
- 論文の詳細を見る
Immunohistochemical analysis can help determine the primary site of origin of carcinomas presenting at metastatic sites. Different types of epithelium, and their corresponding carcinomas, express different subsets of cytokeratins. Thus, antibodies to unique cytokeratins, such as "high molecular weight" cytokeratins, cytokeratin 7, cytokeratin 8, and cytokeratin 20, can help distinguish among different types of carcinomas that may have similar histologic appearances. Also helpful in this analysis are antibodies to the CEA family of proteins, as carcinomas of different sites vary widely in the quantitative and qualitative expression of these proteins. Another approach is the use of antibodies to vimentin, the intermediate filament protein that is co-expressed along with cytokeratin in a limited subset of carcinomas. Additionally, determination of primary site of origin of carcinomas can be assisted by the use of organ-associated markers such as prostatic specific antigen (prostate), gross cystic disease fluid protein-15 (breast), mesothelin (ovary, mesothelium), and thyroid transcription factor-1 (lung, thyroid). Selection of the appropriate subset of these antibodies can be most helpful in clinical situations where there is a limited set of possible primary sites (e.g., breast vs. lung or bladder vs. prostate).
- 日本組織細胞化学会の論文
著者
-
Gown A
Pheno Path Laboratories Seattle Wa University Of British Columbia Vancouver B.c. And Jefferson Medic
-
Gown Allen
Pheno Path Laboratories, Seattle, WA, University of British Columbia, Vancouver, B.C. and Jefferson
関連論文
- Uses of Antibody Panels in the Analysis of Metastatic Carcinomas of Unknown Primary (Symposium VIIIDiagnostic Histochemistry : Recent Advances and Applications)
- P1-11 Multispectral imaging for multicolor immunohistochemical and transmission in-situ hybridization
- S6-2 Correlation of FISH and IHC in low level alterations of HER-2/neu